Clinical Utility of Rapid Plasma Neutrophil Gelatinase-Associated Lipocalin Assays for Diagnosing Acute Kidney Injury in Critically Ill Newborn Infants
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Neutrophil gelatinase-associated lipocalin (NGAL) has been identified as an early marker of acute kidney injury (AKI). This study was designed to evaluate the clinical utility of the rapid plasma NGAL assay for diagnosing AKI in critically ill newborn infants in the neonatal intensive care unit (NICU). Methods: The medical records of 178 critically ill newborn infants >34 weeks of gestational age who underwent plasma NGAL measurement during the first week of life in the Korea University Ansan Hospital NICU from February 2011 to August 2015 were retrospectively reviewed. Plasma NGAL levels were measured at bedside by using a commercial competitive immunoassay kit simultaneously with serum creatinine (Cr) level determination. Results: Of 178 newborn infants enrolled in this study (study group), 25 infants had AKI (AKI group) while 153 infants had no AKI (control group). The plasma NGAL level in the AKI group (114.0 [76.5–281.5] ng/mL) was significantly higher than that in the control group (74.0 [52.5–122.5] ng/mL, P=0.001). Moreover, plasma NGAL levels were found to be correlated with serum Cr levels in the study group (r=0.208, P= 0.005). Plasma NGAL achieved an area under the receiver operating characteristic curve of 0.705 for detecting AKI (95% confidence interval: 0.593–0.817). The best cutoff plasma NGAL level for AKI diagnosis was 100 ng/mL. Conclusion: The rapid plasma NGAL assay has diagnostic value for AKI in critically ill newborn infants >34 weeks of gestational age. Further investigations with a larger population are needed to confirm the potential use of plasma NGAL levels for diagnosing AKI in newborn infants.
Abstract
Purpose: Neutrophil gelatinase-associated lipocalin (NGAL) has been identified as an early marker of acute kidney injury (AKI). This study was designed to evaluate the clinical utility of the rapid plasma NGAL assay for diagnosing AKI in critically ill newborn infants in the neonatal intensive care unit (NICU). Methods: The medical records of 178 critically ill newborn infants >34 weeks of gestational age who underwent plasma NGAL measurement during the first week of life in the Korea University Ansan Hospital NICU from February 2011 to August 2015 were retrospectively reviewed. Plasma NGAL levels were measured at bedside by using a commercial competitive immunoassay kit simultaneously with serum creatinine (Cr) level determination. Results: Of 178 newborn infants enrolled in this study (study group), 25 infants had AKI (AKI group) while 153 infants had no AKI (control group). The plasma NGAL level in the AKI group (114.0 [76.5–281.5] ng/mL) was significantly higher than that in the control group (74.0 [52.5–122.5] ng/mL, P=0.001). Moreover, plasma NGAL levels were found to be correlated with serum Cr levels in the study group (r=0.208, P= 0.005). Plasma NGAL achieved an area under the receiver operating characteristic curve of 0.705 for detecting AKI (95% confidence interval: 0.593–0.817). The best cutoff plasma NGAL level for AKI diagnosis was 100 ng/mL. Conclusion: The rapid plasma NGAL assay has diagnostic value for AKI in critically ill newborn infants >34 weeks of gestational age. Further investigations with a larger population are needed to confirm the potential use of plasma NGAL levels for diagnosing AKI in newborn infants.
참고문헌 (32)
- Schrier RW, "Acute renal failure: definitions, diagnosis, pathogenesis, and therapy", J Clin Invest, 114, pp.5~14 (2004)
- Timovska SN, "Acute kidney injury in newborns", Pril (Makedon Akad Nauk Umet Odd Med Nauki), 36, pp.83~89 (2015)
- Abitbol CL, "Long-term follow-up of extremely low birth weight infants with neonatal renal failure", Pediatr Nephrol, 18, pp.887~893 (2003)
- Cuzzolin L, "Postnatal renal function in preterm newborns: a role of diseases, drugs and therapeutic interventions", Pediatr Nephrol, 21, pp.931~938 (2006)
- Ramasethu J, "Complications of vascular catheters in the neonatal intensive care unit", Clin Perinatol, 35, pp.199~222 (2008)
- Koralkar R, "Acute kidney injury reduces survival in very low birth weight infants", Pediatr Res, 69, pp.354~358 (2011)
- Selewski DT, "Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population", Intensive Care Med, 40, pp.1481~1488 (2014)
- Atiyeh BA, "Evaluation of renal function during childhood", Pediatr Rev, 17, pp.175~180 (1996)
- Abrahamson DR, "Glomerulogenesis in the developing kidney", Semin Nephrol, 11, pp.375~389 (1994)
- Askenazi DJ, "Acute kidney injury in critically ill newborns: what do we know? What do we need to learn?", Pediatr Nephrol, 24, pp.265~274 (2009)
- Goldstein SL, "Kidney function assessment in the critically ill child: is it time to leave creatinine behind?", Crit Care, 11, pp.141~ (2007)
- Genc G, "Kidney injury molecule-1 as a promising biomarker for acute kidney injury in premature babi", Am J Perinatol, 30, pp.245~252 (2013)
- Sarafidis K, "Serum and urine acute kidney injury biomarkers in asphyxiated neonates", Pediatr Nephrol, 27, pp.1575~1582 (2012)
- Unal E, "Serum interleukin-18 as an early marker of acute kidney injury following open heart surgery", Turk Gogus Kalp Dama, 22, pp.483~488 (2014)
- Krawczeski CD, "Serum cystatin C is an early predictive biomarker of acute kidney injury after pediatric cardiopulmonary bypass", Clin J Am Soc Nephrol, 5, pp.1552~1557 (2010)
- Mishra J, "Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury", J Am Soc Nephrol, 14, pp.2534~2543 (2003)
- El-Farghali OG, "Serum neutrophil gelatinase-associated lipocalin as a predictor of acute kidney injury in critically-ill neonates", Pak J Biol Sci, 15, pp.231~237 (2012)
- Zappitelli M, "Urine neutrophil gelatinase-associated lipocalin is an early marker of acute kidney injury in critically ill children: a prospective cohort study", Crit Care, 11, pp.R84~ (2007)
- Nickolas TL, "Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury", Ann Intern Med, 148, pp.810~819 (2008)
- Krawczeski CD, "Neutrophil gelatinase-associated lipocalin concentrations predict development of acute kidney injury in neonates and children after cardiopulmonary bypass", J Pediatr, 158, pp.1009~1015 (2011)
- Askenazi DJ, "Urine biomarkers predict acute kidney injury and mortality in very low birth weight infants", J Pediatr, 159, pp.907~912 (2011)
- Raggal NE, "Serum neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury in asphyxiated neonates", Indian Pediatr, 50, pp.459~462 (2013)
- Selewski DT, "Acute kidney injury in asphyxiated newborns treated with therapeutic hypothermia", J Pediatr, 162, pp.725~729 (2013)
- Selewski DT, "Neonatal acute kidney injury", Pediatrics, 136, pp.e463~e473 (2015)
- Herget-Rosenthal S, "Early detection of acute renal failure by serum cystatin C", Kidney Int, 66, pp.1115~1122 (2004)
- Gallini F, "Progression of renal function in preterm neonates with gestational age ≤32 weeks", Pediatr Nephrol, 15, pp.119~124 (2000)
- Uttenthal LO, "NGAL: a marker molecule for the distressed kidney", Clin Lab Int, 29, pp.39~41 (2005)
- Jiang L, "Could blood neutrophil gelatinase-associated lipocalin (NGAL) be a diagnostic marker for acute kidney injury in neonates? A systemic review and meta-analysis", Clin Lab, 61, pp.1815~1820 (2015)
- Baumert M, "Serum NGAL and copeptin levels as predictors of acute kidney injury in asphyxiated neonates", Clin Exp Nephrol, 21, pp.658~664 (2017)
- Aggarwal A, "Evaluation of renal functions in asphyxiated newborns", J Trop Pediatr, 51, pp.295~299 (2005)
- Gupta B, "Renal failure in asphyxiated neonates", Indian Pediatr, 42, pp.928~934 (2005)
- Bellomo R, "Acute kidney injury", Lancet, 380, pp.756~766 (2012)